Tourette Syndrome Clinical Trial
Official title:
MEG Study of Altered Sensory Processing in Tourette Syndrome: An Exploration of Sensory Tics
This study will examine brain activity associated with the involuntary urges or uncontrolled
movements, called "tics," experienced by people who have Tourette syndrome (TS). Before
people with TS actually develop a tic, whether it is a movement or a vocal tic (like a cough
or bark), they feel the urge to tic. This study will look at brain activity during the time
of this urge and how brain activity may differ in people with TS and without TS.
Healthy normal volunteers and patients with TS between 14 and 65 years of age may be eligible
for this study. Patients must have sensory tics in the facial region and must experience at
least a moderate premonitory urge. Candidates are screened with a medical history, brief
physical examination, and a questionnaire.
Participants undergo the following procedures:
- Magnetoencephalography (MEG): This test records magnetic field changes produced by brain
activity. During the test, the subjects are seated in the MEG recording room and a cone
containing magnetic field detectors is lowered onto their head. Electrodes (small metal
disks) are placed on both sides of the face near the jaw. The recording may be made
while the subject receives small currents from the electrodes on the jaw. Subjects may
be asked a few questions about what they felt during the procedure.
- Magnetic resonance imaging (MRI): This test uses a strong magnetic field and radio waves
to obtain images of body organs and tissues. During the procedure, the subject lies on a
table that can slide in and out of the scanner-a metal cylinder. Subjects may be asked
to lie still for up to 30 minutes at a time. They can communicate with the staff at any
time during the scan.
- Somatosensory evoked responses: This test examines how sensory information travels form
the nerves to the spinal cord and brain in the nervous system. An electrode placed on
the arm, leg, or face delivers a small electrical stimulus that may tingle and cause a
twitch of a hand, foot, or face muscle. Additional electrodes may sometimes be placed on
the scalp, neck, and over the collarbone to record how the impulse from the stimulus
travels over nerve pathways.
Patients in the study are contacted for follow-up after the study. Follow-up will be
conducted by phone or email, according to the patients' convenience, and will consist of
reaffirming that there were no adverse events.
OBJECTIVES:
This study will examine the spatiotemporal dynamics of sensory tics in patients with Tourette
syndrome (TS). We will also investigate the possible existence of a sensory gating problem.
By investigating somatosensory evoked responses from stimulation of the trigeminal nerve
(tSERs) on affected versus unaffected sides of the face, we hope to identify differences in
the SER waveforms that suggest sensory abnormalities. We will use a series of short trains of
stimulations on the affected side to examine habituation, subsequently performing a time-
frequency analysis to seek indicators of decreased sensory gating. This study will examine,
specifically:
Whether the cortical neurocircuitry involved in the elicitation of tSERs differs in patients
with tic disorders from controls.
If SERs differ in a sensory tic facial region of patients, compared to the same spot on an
unaffected side of the face.
Whether in controls and patients with sensory tics on both sides of their body, tSERs on both
sides of the face are symmetrical.
If there is a lack of habituation in tic patients to tSERs in a short-train click paradigm,
compared to controls.
The location for sources of abnormalities in either paradigm.
STUDY POPULATION:
Twenty patients and 10 control subjects will be studied. Subjects can be of any race, gender,
handedness, or age between 14 and 65 years.
DESIGN:
This study will compare tSERs in normal volunteers to those in TS patients. Patients with
bilateral sensory tics will be contrasted with those who have unilateral sensory tics,
comparing power of the response at latencies on affected versus unaffected sides. Subjects
will be seated in the MEG and instructed to "feel the delivered sensation, and try not to tic
for seventy seconds, without counting". The trigeminal nerve will be electrically stimulated
at 0.25 Hz for 30 seconds, which will be followed by head localization and subsequent rest
for tic release. To evaluate sensory gating, the design is similar except the trigeminal
stimulation will occur in short trains. Patients will be surveyed to determine if the
instructions intensified sensory tics.
OUTCOME MEASURES:
We will compare the power of averaged tSERs at latencies, comparing face sides in patients
and comparing patients' active face side with controls' dominant face side. The power of
frequency components at latencies will be considered. We will locate the sources of
differential tSER activity.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04851678 -
Longitudinal Impact of Stressors in Adults With Tourette Syndrome
|
||
Completed |
NCT02605902 -
Trial to Demonstrate the Efficacy and Safety of Internet-delivered Behavioral Treatment for Adults With Tic Disorders
|
N/A | |
Completed |
NCT04007913 -
Incorporating teleCBIT Into a Hospital-Based Tic Program
|
N/A | |
Completed |
NCT02900144 -
Modified Comprehensive Behavioral Intervention for Tics (M_CBIT)
|
N/A | |
Completed |
NCT02216474 -
Brain Stimulation in Movement Disorders
|
N/A | |
Completed |
NCT02256475 -
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
|
Phase 1 | |
Completed |
NCT01329198 -
Brain Stimulation for the Treatment of Tourette Syndrome
|
N/A | |
Terminated |
NCT00952601 -
Pilot Study of the Modified Atkins Diet for Tourette Syndrome
|
Phase 1 | |
Enrolling by invitation |
NCT00355927 -
Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
|
N/A | |
Completed |
NCT00206323 -
A Randomized, Placebo-controlled, Tourette Syndrome Study.
|
Phase 3 | |
Completed |
NCT00004376 -
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder
|
Phase 3 | |
Completed |
NCT04498364 -
Extinction Learning in Adults With Tourette Syndrome
|
N/A | |
Completed |
NCT00755339 -
Role of the Sensory Experience in Generating Motor Tics in Tourette Syndrome
|
||
Completed |
NCT03325010 -
Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT06081348 -
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
|
Phase 2 | |
Completed |
NCT01702077 -
Neurofeedback for Tourette Syndrome
|
N/A | |
Completed |
NCT01719523 -
Open-Trial of EPI-743 for Adults With Tourette Syndrome
|
Phase 1 | |
Completed |
NCT00231985 -
Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder
|
Phase 2 | |
Completed |
NCT00206336 -
An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.
|
Phase 3 | |
Terminated |
NCT03732534 -
Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome
|
Phase 2 |